Opportunity Information: Apply for CDC RFA GH13 1364
Apply for CDC RFA GH13 1364
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Technical Collaboration with the Peoples Republic of China (PRC) on Innovative Approaches to Increase the Effectiveness of the HIV/AIDS Response in China and Globally under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Feb 1, 2013 and posted on Feb 1, 2013.
- Applicants must submit their applications by Apr 10, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $10,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $2,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The Chinese Center for Disease Control and Prevention s National Center for AIDS/STD Prevention and Control (NCAIDS) was officially established in 1998 as the primary implementation unit of the national HIV/AIDS response in China. As such, NCAIDS is responsible for the following activities 1) assist the Ministry of Health of the People s Republic of China in the development of evidence based policy and regulations for HIV/AIDS prevention and control 2) develop the national action plan for HIV/AIDS prevention and control and develop the technical strategies and measures to implement the plan 3) organize surveys, analysis and projections of the AIDS epidemic in China, and manage HIV/AIDS epidemic disease reporting 4) collect and exchange information on AIDS prevention and control domestically and internationally 5) provide technical guidance on national professional human resources development for HIV/AIDS prevention and control 6) organize and conduct research concerning the strategies of HIV/AIDS prevention and control, epidemiology, health education and intervention, treatment and care, AIDS etiology, immunology and laboratory technologies and 7) organize and implement AIDS cooperation and exchange programs between the national government, multilateral and bilateral organizations.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA GH13-1364) is a Centers for Disease Control and Prevention (CDC) cooperative agreement under PEPFAR focused on technical collaboration with the Peoples Republic of China (PRC) to strengthen HIV/AIDS prevention, care, treatment, and laboratory science. The core aim is to jointly develop and refine innovative, evidence-based models that help China meet its national HIV/AIDS targets while also generating approaches, lessons, and tools that can be shared internationally to improve HIV responses in other settings. In practice, the opportunity is framed as a collaboration that supports both domestic impact in China and broader global learning, reflecting PEPFARs interest in scalable strategies and cross-country knowledge transfer.
The award mechanism is a discretionary cooperative agreement, which generally indicates substantial involvement by CDC in the work compared with a standard grant. The program is categorized under health, with CFDA/Assistance Listing number 93.067 (Global AIDS). The funding profile listed an estimated total of $10,000,000, with an award ceiling of $2,000,000 and an award floor of $0, and CDC anticipated making one award. There was no cost-sharing or matching requirement stated, meaning the recipient would not be required to contribute non-federal funds as a condition of the award. Key dates included a posted date of February 1, 2013, and an application closing date of April 10, 2013, with the opportunity later archived on May 10, 2013.
Eligibility is effectively directed to a specific Chinese governmental technical institution: the National Center for AIDS/STD Prevention and Control (NCAIDS) within the Chinese Center for Disease Control and Prevention. The announcement explains that NCAIDS, established in 1998, serves as the primary implementation unit for Chinas national HIV/AIDS response, which clarifies why the opportunity is structured around collaboration with that entity. The eligibility language signals that the recipient is expected to be an organization with the national mandate, infrastructure, and authority to influence policy, implement technical strategies, manage surveillance, and coordinate partnerships at a countrywide level.
The opportunity outlines NCAIDSs central responsibilities, which also function as the functional scope for the collaboration. These responsibilities include assisting the Ministry of Health in developing evidence-based HIV/AIDS policies and regulations; developing national action plans and the technical strategies to implement them; conducting surveys, analyses, and projections of the HIV epidemic and managing case and disease reporting systems; collecting and exchanging HIV/AIDS prevention and control information domestically and internationally; providing technical guidance for national workforce and professional capacity development; organizing and conducting research across key areas such as prevention strategies, epidemiology, health education and interventions, treatment and care, and laboratory technologies; and organizing and implementing cooperation and exchange programs with national government bodies and multilateral and bilateral partners. Taken together, these elements indicate the program is meant to support a mix of applied public health implementation, technical assistance, operations and epidemiologic analysis, and targeted research and evaluation, with strong emphasis on translating evidence into national practice.
Because the stated purpose is to develop innovative models across prevention, care, treatment, and laboratory science, the work would reasonably encompass improving the effectiveness of service delivery and the technical quality of HIV programs, potentially including new approaches to reaching key populations, strengthening linkage to care, improving retention and adherence, optimizing antiretroviral treatment programming, and enhancing laboratory systems that support diagnosis and monitoring. The explicit reference to sharing experiences globally suggests an expectation that the collaboration would produce transferable knowledge products such as implementation guidance, documented best practices, evaluation findings, and lessons learned that could inform other countries HIV responses, especially those working toward similar targets in epidemic control.
Administrative and applicant support information is provided through the CDC Procurement and Grants Office Technical Information Management (PGOTIM), including a phone number and email address for assistance accessing the full announcement. Overall, the opportunity is best understood as a single-recipient, CDC-involved technical partnership with Chinas national HIV/AIDS technical lead (NCAIDS), funded under PEPFAR, intended to generate improved HIV program models in China and make the resulting strategies and evidence useful beyond China through formal knowledge exchange and dissemination.
Frequently Asked Questions (FAQs)
What is the funding opportunity?
This opportunity is CDC RFA GH13-1364, a Centers for Disease Control and Prevention (CDC) cooperative agreement under PEPFAR. It focuses on technical collaboration with the Peoples Republic of China (PRC) to strengthen HIV/AIDS prevention, care, treatment, and laboratory science.
What is the main purpose of this cooperative agreement?
The core purpose is to jointly develop and refine innovative, evidence-based models that help China meet its national HIV/AIDS targets while also generating approaches, lessons, and tools that can be shared internationally to improve HIV responses in other settings.
How is this opportunity framed in terms of impact?
It is framed as a collaboration that supports domestic impact in China and broader global learning. The emphasis aligns with PEPFAR interest in scalable strategies and cross-country knowledge transfer.
What type of award mechanism is used?
The mechanism is a discretionary cooperative agreement, which indicates substantial involvement by CDC in the work compared with a standard grant.
What is the program category and Assistance Listing (CFDA) number?
The program is categorized under health with CFDA/Assistance Listing number 93.067 (Global AIDS).
How much funding is available?
The funding profile lists an estimated total of $10,000,000.
What are the award ceiling and award floor?
The award ceiling is $2,000,000 and the award floor is $0.
How many awards did CDC anticipate making?
CDC anticipated making one award.
Is cost sharing or matching required?
No cost-sharing or matching requirement is stated. The recipient would not be required to contribute non-federal funds as a condition of the award.
Who is eligible to apply?
Eligibility is effectively directed to a specific Chinese governmental technical institution: the National Center for AIDS/STD Prevention and Control (NCAIDS) within the Chinese Center for Disease Control and Prevention.
Why is eligibility directed to NCAIDS?
The announcement describes NCAIDS (established in 1998) as the primary implementation unit for Chinas national HIV/AIDS response. The eligibility language indicates the recipient is expected to have the national mandate, infrastructure, and authority to influence policy, implement technical strategies, manage surveillance, and coordinate partnerships nationwide.
What kinds of activities are within the scope of the collaboration?
The scope is tied to NCAIDS responsibilities and includes a mix of applied public health implementation, technical assistance, operations and epidemiologic analysis, and targeted research and evaluation, with an emphasis on translating evidence into national practice.
What responsibilities and functions does NCAIDS have that relate to this work?
The announcement outlines NCAIDS responsibilities including: assisting the Ministry of Health in developing evidence-based HIV/AIDS policies and regulations; developing national action plans and technical implementation strategies; conducting surveys, analyses, and projections of the HIV epidemic and managing case and disease reporting systems; collecting and exchanging HIV/AIDS prevention and control information domestically and internationally; providing technical guidance for workforce and professional capacity development; organizing and conducting research (prevention strategies, epidemiology, health education and interventions, treatment and care, and laboratory technologies); and organizing cooperation and exchange programs with government bodies and multilateral and bilateral partners.
Which HIV program areas are emphasized?
The purpose explicitly covers HIV/AIDS prevention, care, treatment, and laboratory science, with the intent to develop innovative, evidence-based models across these areas.
What kinds of improvements might the work reasonably include?
Based on the stated purpose, it could encompass improving service delivery effectiveness and technical quality of HIV programs, potentially including new approaches to reaching key populations, strengthening linkage to care, improving retention and adherence, optimizing antiretroviral treatment programming, and enhancing laboratory systems supporting diagnosis and monitoring.
Is there an expectation to share results outside of China?
Yes. The opportunity explicitly references sharing experiences globally, suggesting an expectation to produce transferable knowledge products such as implementation guidance, documented best practices, evaluation findings, and lessons learned to inform other countries HIV responses.
What are the key dates for this opportunity?
The posted date was February 1, 2013, and the application closing date was April 10, 2013. The opportunity was later archived on May 10, 2013.
Where can applicants get administrative or technical help related to the announcement?
Administrative and applicant support is provided through the CDC Procurement and Grants Office Technical Information Management (PGOTIM), with a phone number and email address available for assistance accessing the full announcement.
What does the cooperative agreement nature of the award imply for project implementation?
Because it is a cooperative agreement, it implies substantial CDC involvement in the work compared with a standard grant, consistent with a CDC-involved technical partnership approach.
How should this opportunity be summarized at a high level?
It is a single-recipient, CDC-involved technical partnership with Chinas national HIV/AIDS technical lead (NCAIDS), funded under PEPFAR, intended to generate improved HIV program models in China and make resulting strategies and evidence useful beyond China through formal knowledge exchange and dissemination.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Systems Biology Enabled Research on the Role of Microbial Communities in Carbon Cycling
Previous opportunity: (RFI) Automotive Fuel Cell Cost and Durability Targets
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 1364
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 1364) also looked into and applied for these:
| Funding Opportunity |
|---|
| Disorders of Human Communication Effectiveness, Outcomes and Health Services Research (R21) Apply for PA 13 103 Funding Number: PA 13 103 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Disorders of Human Communication Effectiveness, Outcomes and Health Services Research (R01) Apply for PA 13 102 Funding Number: PA 13 102 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High End Instrumentation Grant Program (S10) Apply for PAR 13 101 Funding Number: PAR 13 101 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Limited Competition Global Health Research and Research Training eCapacity Initiative (R25) Apply for PAR 13 107 Funding Number: PAR 13 107 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| APS for Microbicide Research, Development, and Introduction, Round 2 Apply for APS OAA 13 000001 Funding Number: APS OAA 13 000001 Agency: Agency for International Development Category: Health Funding Amount: $168,000,000 |
| Affordable Care Act Health Center Controlled Networks Apply for HRSA 13 267 Funding Number: HRSA 13 267 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Maternal and Child Health (MCH) Nutrition Training Program Apply for HRSA 13 180 Funding Number: HRSA 13 180 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Genomic Centers for Infectious Diseases (U19) Apply for RFA AI 13 009 Funding Number: RFA AI 13 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| MCH Knowledge to Practice Program Apply for HRSA 13 197 Funding Number: HRSA 13 197 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Dental Reimbursement Program Apply for HRSA 13 171 Funding Number: HRSA 13 171 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| MCH Navigator Program Apply for HRSA 13 262 Funding Number: HRSA 13 262 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Grants to Expand the Use of Technology Assisted Care in Targeted Areas of Need Apply for TI 13 008 Funding Number: TI 13 008 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $280,000 |
| High Impact Neuroscience Research Resource Grants (R24) Apply for RFA NS 13 009 Funding Number: RFA NS 13 009 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Innovative and Novel Approaches toward Inner Ear Regenerative Therapies by Early Stage Investigators (R01) Apply for RFA DC 13 002 Funding Number: RFA DC 13 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improvement of Animal Models for Stem Cell Based Regenerative Medicine (R24) Apply for PAR 13 113 Funding Number: PAR 13 113 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improvement of Animal Models for Stem Cell Based Regenerative Medicine (R21) Apply for PAR 13 115 Funding Number: PAR 13 115 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Enhancing Opioid Treatment Program Patient Continuity of Care through Data Interoperability Apply for TI 13 010 Funding Number: TI 13 010 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $50,000 |
| NINDS Institutional Center Core Grants to Support Neuroscience Research (P30) Apply for PAR 13 116 Funding Number: PAR 13 116 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| STD Surveillance Network (SSuN) Apply for CDC RFA PS13 1306 Funding Number: CDC RFA PS13 1306 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,100,000 |
| Revision Applications for Research on Assessing the Role of Stigma in HIV Prevention and Care (R34) Apply for RFA MH 14 141 Funding Number: RFA MH 14 141 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 1364", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.